Features

• Overcoming Depression
  By Lisa Capaldini, M.D., and George Harrison, M.D.
• Oral Health and HIV
  By David I. Rosenstein, D.M.D., M.P.H.
• Insulin Resistance and Diabetes
  By Liz Highleyman

Departments

• Editor's Note
  By Nicholas Cheonis
• In Their Own Words: AIDS Advocates
• News Briefs
  By Liz Highleyman
• Tipranavir: The First Nonpeptidic Protease Inhibitor
  By Nicholas Cheonis
• Women and HIV: Mother-to-Child Transmission -- How Will AZT and Nevirapine Use for MTCT Affect Future Treatment?
  By Theo Smart
• Open Clinical Trials

Notice

The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.

Bulletin of Experimental Treatments for AIDS Editorial Staff: Editor: Nicholas Cheonis Copy Editor: Liz Highleyman Design and Production Manager: Paula Fener Contributors to this issue: Lisa Capaldini, M.D.; Nicholas Cheonis; George Harrison, M.D.; Liz Highleyman; David I. Rosenstein, D.M.D., M.P.H.; Theo Smart Scientific Advisory Committee: George Beatty, M.D., M.P.H.; Lisa Capaldini, M.D.; Eric Goosby, M.D.; Cristina Gruta, Pharm.D.; Gregory Pauxtis, M.D. Copyright BETA is published biannually by the San Francisco AIDS Foundation. Funding provided by private and corporate donations. Copyright © 2004 by the San Francisco AIDS Foundation. All rights reserved. Articles may be reproduced for free distribution with acknowledgment of BETA and the author(s); for other uses, contact the editors. Brief passages may be quoted for review. Library of Congress ISSN 1058-708X. Editorial office and mailing address: P.O. Box 426182 San Francisco, CA 94142-6182 Telephone: (415) 487-8060 Fax: (415) 487-8069 E-mail: beta@sfaf.org URL: www.sfaf.org ©2004 San Francisco AIDS Foundation